Rare diseases
Investigational molecules
Locations
Back to Italy10 clinical trials in Gussago, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on amyotrophic lateral sclerosis (ALS), investigating the effects of acetyl-L-carnitine on functional disability progression. The trials aim to evaluate different dosage regimens to optimize treatment outcomes for patients.
These studies represent significant advancement in understanding ALS treatment options.
Groundbreaking research evaluating Spinal Muscular Atrophy (SMA) treatments, specifically testing Taldefgropeb Alfa in combination with existing therapies. The studies focus on measuring motor function improvements in patients.
This research aims to enhance therapeutic outcomes for SMA patients through innovative treatment combinations.
Clinical trials investigating new treatments for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), focusing on nipocalimab's efficacy in preventing disease relapse in responsive patients.
These studies represent crucial advances in managing chronic neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
